如果说兽药GMP的规范实施是一场针对兽药生产企业革命的话,那么随之而来的可能就是针对兽药经销业的二次革命!作为兽药经销商的我们既不能继续睡在过去的行业温床上梦回过去,更不能站在一旁笑看兽药企业如何兴衰、淘汰、兼并、挣扎、成长或壮大,因为无形的风雨也将在我们经营者的天空刮起。为什么呢?首先,行业管理体制的日趋完善,动物药品业从业门槛提高;其次,动物药品企业GMP实施后,行业主动权、平衡点将向药品生产企业倾斜偏向转移;再次,单一靠资本运营的陈旧经营模式将被科技化、信息化的经营方式逐步取代;最后,渠道的扁平化发展趋势将削减中间环节的经营机构在渠道链上的作用。因此,GMP时代兽药经营者应从国家对兽药企业的GMP化中得到启示,持未雨绸缪之心,革新思维,随行业发展齐跑,把自己炼就成未来兽药市场所需的新型经销商。 If the regulation of veterinary drug GMP is a revolution against the veterinary drug manufacturer, the ensuing second revolution may be for the veterinary drug dealership industry. As a veterinary drug dealer, we can neither continue to sleep in the past industry hotbed Back in the past, but can not stand aside smile to see how the veterinary drug business rise and fall, elimination, mergers, struggles, growth or growth, because the invisible wind and rain will also be blowing in the sky of our operators. Why? First of all, the industry management system is becoming more sophisticated, animal medicine industry practitioners to raise the threshold; Second, after the implementation of GMP animal drugs, the industry initiative, the balance point will shift bias to the pharmaceutical manufacturers; Third, relying solely on capital operation The outdated business model will be replaced by a technology-based and informationized business model. Finally, the flat development trend of the channel will reduce the role of middle-level business organizations in the channel chain. Therefore, veterinary drug operators in the GMP era should get enlightenment from the state’s GMP in veterinary drug enterprises, take precocious minds, innovate their thinking, run along with the development of the industry, and transform themselves into new dealers needed in the future veterinary drug market.